anti-VEGF antibody product blog
Tags: Antibody; Vascular Endothelial Growth Factor; VEGF; Polyclonal Antibody; anti-VEGF antibody;
The VEGF vegfa (Catalog #MBS340507) is an Antibody produced from Sheep and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Vascular Endothelial Growth Factor (VEGF) can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB), Dot Blot (DB), Immunohistochemistry (IHC), Immunoassays, Development of Rapid tests and Other Immunoassay, Antibody Recognition Assays. Researchers should empirically determine the suitability of the VEGF vegfa for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.The VEGF vegfa product has the following accession number(s) (GI #181971) (NCBI Accession #AAA35789.1) (Uniprot Accession #P15692). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
VEGF is a heparin-binding glycoprotein, which can exist in a number of different isoforms. The protein has been found to be a potent inducer of angiogeneis and endothelial cell proliferation and plays an important role in regulating vasculogenesis. VEGF can be detected in both the plasma and serum and has been implicated in several disease states associated with augmented angiogenesis. Recombinant VEGF (165) comprises a 165 amino acid fragment (5-169) corresponding to the VEGF 165 isoform and is expressed in E Coli with an aminoterminal hexahistidine tag. This product is for research use only.
Immunogen: Recombinant Human VEGF. Buffer: 20mM Phosphate, 150mM Sodium Chloride
Preservative: 0.09% Sodium Azide. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing VEGF are readily searchable from our website. Different antibodies against the same target such as VEGF may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. VEGF also interacts with the following gene(s): FLT1, HIF1A, IGF1, KDR, MMP9, NRP1, PGF, SRC, TGFB1, VWF. Blood, Bone, Embryonic Tissue, Eye, Heart, Kidney, Liver, Lung, Muscle, Vascular tissues are correlated with this protein. Adenocarcinoma, Diabetes Complications, Diabetic Retinopathy, Heart Diseases, Inflammation, Lung Diseases, Macular Edema, Neoplasm Metastasis, Neovascularization, Pathologic, Retinal Diseases are some of the diseases may be linked to Vascular Endothelial Growth Factor (VEGF). The following patways have been known to be associated with this gene.